Varicella is a serious infection in the immunocompromised patient. Prophylaxis with varicella zoster immune globulin is known to decrease the incidence of severe varicella infection. The titers of antibody to varicella zoster virus were compared in patients who received either varicella zoster immune globulin or intravenous immune globulin, 4 ml or 6 ml/kg per dose. The titers of antibody to varicella zoster virus were comparable in each group.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0002-9343(84)90330-9 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!